Inhibition of MASTL in colon cancer cells induced chemosensitivity to 5‐FU with downregulation of Survivin and Bcl‐xL expression, whereas MASTL depletion in breast cancer cells enhanced the radiosensitivity with increased PP2A activity. The gene discussed is MASTL; the disease is breast carcinoma.